307 related articles for article (PubMed ID: 8227125)
1. The v-sis protein retains biological activity as a type II membrane protein when anchored by various signal-anchor domains, including the hydrophobic domain of the bovine papilloma virus E5 oncoprotein.
Xu YF; Meyer AN; Webster MK; Lee BA; Donoghue DJ
J Cell Biol; 1993 Nov; 123(3):549-60. PubMed ID: 8227125
[TBL] [Abstract][Full Text] [Related]
2. The v-sis oncoprotein loses transforming activity when targeted to the early Golgi complex.
Hart KC; Xu YF; Meyer AN; Lee BA; Donoghue DJ
J Cell Biol; 1994 Dec; 127(6 Pt 2):1843-57. PubMed ID: 7806564
[TBL] [Abstract][Full Text] [Related]
3. Identification of amino acids in the transmembrane and juxtamembrane domains of the platelet-derived growth factor receptor required for productive interaction with the bovine papillomavirus E5 protein.
Petti LM; Reddy V; Smith SO; DiMaio D
J Virol; 1997 Oct; 71(10):7318-27. PubMed ID: 9311809
[TBL] [Abstract][Full Text] [Related]
4. Intracellular retention of membrane-anchored v-sis protein abrogates autocrine signal transduction.
Lee BA; Donoghue DJ
J Cell Biol; 1992 Sep; 118(5):1057-70. PubMed ID: 1324943
[TBL] [Abstract][Full Text] [Related]
5. Membrane-anchored form of v-sis/PDGF-B induces mitogenesis without detectable PDGF receptor autophosphorylation.
Lee BA; Donoghue DJ
J Cell Biol; 1991 Apr; 113(2):361-70. PubMed ID: 1849139
[TBL] [Abstract][Full Text] [Related]
6. Cell surface retention sequence binding protein-1 interacts with the v-sis gene product and platelet-derived growth factor beta-type receptor in simian sarcoma virus-transformed cells.
Boensch C; Huang SS; Connolly DT; Huang JS
J Biol Chem; 1999 Apr; 274(15):10582-9. PubMed ID: 10187853
[TBL] [Abstract][Full Text] [Related]
7. Transformation-specific interaction of the bovine papillomavirus E5 oncoprotein with the platelet-derived growth factor receptor transmembrane domain and the epidermal growth factor receptor cytoplasmic domain.
Cohen BD; Goldstein DJ; Rutledge L; Vass WC; Lowy DR; Schlegel R; Schiller JT
J Virol; 1993 Sep; 67(9):5303-11. PubMed ID: 8394451
[TBL] [Abstract][Full Text] [Related]
8. Cellular transformation by a transmembrane peptide: structural requirements for the bovine papillomavirus E5 oncoprotein.
Meyer AN; Xu YF; Webster MK; Smith AE; Donoghue DJ
Proc Natl Acad Sci U S A; 1994 May; 91(11):4634-8. PubMed ID: 8197111
[TBL] [Abstract][Full Text] [Related]
9. The bovine papillomavirus E5 protein and the PDGF beta receptor: it takes two to tango.
Talbert-Slagle K; DiMaio D
Virology; 2009 Feb; 384(2):345-51. PubMed ID: 18990418
[TBL] [Abstract][Full Text] [Related]
10. Alanine mutagenesis of conserved residues in the platelet-derived growth factor family: identification of residues necessary for dimerization and transformation.
Maher DW; Strawn LM; Donoghue DJ
Oncogene; 1993 Mar; 8(3):533-41. PubMed ID: 8437840
[TBL] [Abstract][Full Text] [Related]
11. Intracellular turnover, novel secretion, and mitogenically active intracellular forms of v-sis gene product in simian sarcoma virus-transformed cells. Implications for intracellular loop autocrine transformation.
Lokeshwar VB; Huang SS; Huang JS
J Biol Chem; 1990 Jan; 265(3):1665-75. PubMed ID: 2153139
[TBL] [Abstract][Full Text] [Related]
12. Rapid turnover of the platelet-derived growth factor receptor in sis-transformed cells and reversal by suramin. Implications for the mechanism of autocrine transformation.
Huang SS; Huang JS
J Biol Chem; 1988 Sep; 263(25):12608-18. PubMed ID: 2842336
[TBL] [Abstract][Full Text] [Related]
13. Golgi alkalinization by the papillomavirus E5 oncoprotein.
Schapiro F; Sparkowski J; Adduci A; Suprynowicz F; Schlegel R; Grinstein S
J Cell Biol; 2000 Jan; 148(2):305-15. PubMed ID: 10648563
[TBL] [Abstract][Full Text] [Related]
14. An intact PDGF signaling pathway is required for efficient growth transformation of mouse C127 cells by the bovine papillomavirus E5 protein.
Riese DJ; DiMaio D
Oncogene; 1995 Apr; 10(7):1431-9. PubMed ID: 7731695
[TBL] [Abstract][Full Text] [Related]
15. Suramin enters and accumulates in low pH intracellular compartments of v-sis-transformed NIH 3T3 cells.
Huang SS; Koh HA; Huang JS
FEBS Lett; 1997 Oct; 416(3):297-301. PubMed ID: 9373173
[TBL] [Abstract][Full Text] [Related]
16. A single amino acid substitution converts a transmembrane protein activator of the platelet-derived growth factor β receptor into an inhibitor.
Petti LM; Talbert-Slagle K; Hochstrasser ML; DiMaio D
J Biol Chem; 2013 Sep; 288(38):27273-27286. PubMed ID: 23908351
[TBL] [Abstract][Full Text] [Related]
17. The transmembrane domain of the E5 oncoprotein contains functionally discrete helical faces.
Adduci AJ; Schlegel R
J Biol Chem; 1999 Apr; 274(15):10249-58. PubMed ID: 10187811
[TBL] [Abstract][Full Text] [Related]
18. Deletion mutation in the signal anchor domain activates cleavage of the influenza virus neuraminidase, a type II transmembrane protein.
Hogue BG; Nayak DP
J Gen Virol; 1994 May; 75 ( Pt 5)():1015-22. PubMed ID: 8176363
[TBL] [Abstract][Full Text] [Related]
19. Cloning, expression, characterization, and role in autocrine cell growth of cell surface retention sequence binding protein-1.
Huang SS; Tang FM; Huang YH; Liu IH; Hsu SC; Chen ST; Huang JS
J Biol Chem; 2003 Oct; 278(44):43855-69. PubMed ID: 12912978
[TBL] [Abstract][Full Text] [Related]
20. The v-sis oncogene product but not platelet-derived growth factor (PDGF) A homodimers activate PDGF alpha and beta receptors intracellularly and initiate cellular transformation.
Bejcek BE; Hoffman RM; Lipps D; Li DY; Mitchell CA; Majerus PW; Deuel TF
J Biol Chem; 1992 Feb; 267(5):3289-93. PubMed ID: 1310684
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]